Knight Therapeutics | GUD - Market Capitalization


Knight Therapeutics reported CAD1.01B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 7M 2M Mar/2026
Aurora Cannabis CAD 193.82M 133.39M Mar/2026
Avita Medical AUD 105.47M 35.32M Dec/2025
Canopy Growth CAD 557.13M 99.33M Mar/2026
Cronos Group USD 1.03B 72.12M Jun/2026
Dianthus Therapeutics USD 4.58B 2.8B Mar/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
IQVIA Holdings USD 32.25B 3.62B Jun/2026
Organigram Holdings CAD 252.47M 59.69M Mar/2026
Organon & Co USD 3.56B 1.99B Jun/2026
Revvity USD 12.69B 2.75B Jun/2026
Tectonic Therapeutic USD 580M 190M Mar/2026
Viatris USD 18.49B 2.76B Jun/2026
Xeris Pharmaceuticals USD 1000M 303M Mar/2026